Swiss regulator approves first malaria treatment for newborn babies
In a late-stage clinical trial, pharmaceutical giant Novartis showed the drug was safe and effective for babies weighing less than five kilograms, which they typically reach by two months of age.
Traditionally, these infants have been given either a full or half-dose of the antimalarial drug intended for babies six months or older. But because newborns do not process medicines the same way, there is a higher risk of side effects.
The lack of specialised treatment – and the fact that babies are not vaccinated until they are around five months old – has left the youngest infants relatively unprotected against malaria, a mosquito-borne disease that kills about 597,000 people per year.
Most deaths are among children under five years old in Africa.
It's not clear exactly how many babies are affected, but in 2023, there were an estimated 36 million pregnancies in 33 African countries where malaria is widespread. About one in three mothers were infected with malaria while pregnant, raising the risk that they will pass the disease along to their newborns, according to the World Health Organization (WHO).
'Every one of those [babies] is a potential target for malaria infection,' Dr Lutz Hegemann, president of Novartis' global health programme, told Euronews Health.
'We don't want to leave any patient behind, no matter how small they are'.
Eight African countries – Burkina Faso, Ivory Coast, Kenya, Malawi, Mozambique, Nigeria, Tanzania, and Uganda – are expected to quickly approve the medicine as part of a partnership with Swissmedic, the Swiss drugs regulator.
Hegemann said Novartis hopes to roll the medicine out there this autumn, with more countries to follow, on a not-for-profit basis.
The medicine, known as Coartem Baby, is similar to Novartis' existing drug to treat uncomplicated malaria in young children, but it has a different dose and ratio of ingredients to prevent side effects in the youngest infants.
It also has a sweet cherry flavour and can be dissolved in breast milk to make it easier to give to patients.
'These are small changes, but big steps,' Dr Quique Bassat, head of the Barcelona Institute of Global Health, told Euronews Health.
While the number of newborns with malaria 'still remains relatively modest in terms of the overall burden, those cases need to be treated, and therefore we need better drugs,' he added.
'Now we have something which is perfectly suitable for that specific age group where there was a gap'.
Bassat advised Novartis on the clinical trial, which was funded by the European Union and the Swedish International Development Cooperation Agency.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Euronews
2 days ago
- Euronews
‘Cougar puberty': Why is perimenopause going viral on social media?
After Amanda turned 42, her body began to feel like a stranger's. Suddenly plagued with hot flushes, insomnia, and irregular periods, she also noticed herself becoming overly emotional in response to seemingly small, everyday things. 'I assumed it was all related to stress,' the hospital administrator from the US state of Texas told Euronews Health. But even when life calmed down, the symptoms persisted. 'I reached out to my doctor for some blood work, but all my hormones came back normal, so I was told to wait,' added Amanda, who requested that only her first name be used. 'Then the cycle would begin again'. It was only in the last month – a year since she first went to the doctor – that her blood test results showed she has low ovary production. This confirmed what Amanda had been suspecting: her body was in perimenopause. What is perimenopause? Menopause marks the end of a woman's reproductive cycle, defined by the absence of a period for 12 consecutive months. On average, women experience menopause between ages 45 and 55, according to the World Health Organization (WHO). The time leading up to menopause is known as perimenopause, during which hormone levels begin to fluctuate and decline. Symptoms include poor sleep, hot flushes, brain fog, anxiety, mood swings, and irregular periods, the UK's National Health Service (NHS) states. 'Around one in 30 women under the age of 40 are menopausal, meaning that many young women will also be perimenopausal,' said Dr Louise Newson, a menopause specialist and founder of the Balance app, which provides personalised support for women with menopausal symptoms. 'Factors such as family history, medical conditions, or treatments like surgery or chemotherapy can all lead to menopause occurring at a younger age,' Newson told Euronews Health. Until recently, perimenopause remained under-discussed due to taboos surrounding the subject, according to Newson. This, along with an absence of any official test to diagnose it, has led some women to feel confused, alone, and belittled by others about their symptoms. 'Many friends would dismiss my concerns that I was menopausal because 'they're older and they're fine,'' Amanda said. Delays can be serious. Last year, a UK government report found that women suffering from reproductive health conditions, such as endometriosis, frequently wait years for diagnosis or treatment, in one example of what it called 'medical misogyny'. Perimenopause symptoms in particular can have a significant impact on wellbeing, with almost 40 per cent of women experiencing moderate to severe hot flushes and night sweats, according to a study published in the Lancet Diabetes & Endocrinology. Yet still, it remains significantly under-researched, and many women are misdiagnosed with conditions such as depression, anxiety, arthritis, or fibromyalgia, which causes full body pain and fatigue, according to Newson. That closely mirrors Amanda's experience. 'I went to the doctor multiple times, and they always entertained my requests for testing and appointments. But when nothing would show up, and they'd hear about how stressed I've been, it was mostly dismissed,' said Amanda. 'I don't think they were being intentionally dismissive, but 'stress' really was used as a general explanation for much longer than it should be'. How is perimenopause treated? The main treatment for perimenopause is hormone replacement therapy (HRT), which replaces the body's declining levels of oestrogen and progesterone, according to the UK's NHS. This can be administered via tablets, skin patches, implants, or as a gel or spray for the skin. Testosterone supplementation can be used as a secondary option in those struggling with fatigue and low libido. 'The type of hormones you need and the doses you're given vary between each woman – it is not a 'one type fits all' prescription,' Newson said. 'Talking through your options with a healthcare professional is really important to ensure you get the right treatment choice for you, depending on your individual circumstances,' she added. 'Cougar puberty' and online destigmatisation As awareness of menopausal symptoms has grown, women have found recognition and solidarity in openly discussing their experiences online. Last year, a TikTok user shared that she'd just heard 'the best term' for perimenopause, coining 'cougar puberty'. This humorous rebrand has since gone viral, with others using it to reclaim their experiences and destigmatise the subject. 'Pretty much sums it up, I've been calling it reverse puberty,' reads one TikTok comment. "Cougar puberty... I like the name... try calling ur [sic] hot flashes tropical moments... it sounds like a vacation," said another. 'For too long, perimenopause and menopause were taboo subjects, discussed in whispers or brushed aside as something women simply had to 'get on with,'' Newson said. 'The visibility and shared experiences we're now seeing – especially online – are helping to improve conversations and increase knowledge that should have been part of mainstream healthcare for decades'.
Euronews
4 days ago
- Euronews
How do mineral and chemical sunscreens affect our health?
Mineral sunscreens have gained in popularity in recent years, fueled by claims that they're gentler or safer than their chemical counterparts. But the real differences between the two types of sun protection are more technical than many consumers realise, making it easy to misunderstand what scientists know about their health effects. The differences between these sunscreens mainly come down to their active ingredients and how they block ultraviolet (UV) rays. Chemical sunscreens absorb UV radiation, converting it into heat and releasing it from the skin. Mineral sunscreens, sometimes called physical sunscreens, create a thin barrier that primarily reflects or scatters UV rays away from the skin. Even the terms 'mineral' and 'chemical' can be misleading, though, given all sunscreens use chemicals. Many mineral-based formulas also use other substances, called 'boosters,' to help the active ingredients work better. More accurate descriptors could be 'soluble' sunscreen filters – those that could permeate the skin – and 'insoluble' filters that could not do so, said Christian Surber, a dermatopharmacologist (someone who studies how drugs affect the skin) at the University of Zurich and the University of Basel. 'It's just the mechanism of action [of the filters] that is different,' he told Euronews Health. 'It can be absorption, and it can be scattering'. Euronews Health has chosen to use the terms that consumers are most likely to see when they shop for sunscreens. Sunscreen and health Concerns around how sunscreens affect our health are nothing new, prompting the European Commission Scientific Committee on Consumer Safety (SCCS) to assess the safety of three non-mineral UV filters – oxybenzone, homosalate, and octocrylene – in 2021 over concerns that they may have endocrine-disrupting properties. The SCCS determined that homosalate and oxybenzone were not safe at the concentrations commonly used at the time, and that octocrylene was safe at a concentration up to 10 per cent – though it cautioned that the data was inconclusive. One analysis, for example, estimated that a person would have to apply sunscreen daily for 277 years to experience the same hormone-disrupting effects observed in rats that were fed oxybenzone in a lab. Even so, the European Commission issued new restrictions in 2022 to lower the amount of these filters allowed in sunscreens. 'We pretty much don't see them anymore on the market, because producers know that [they may] cause problems or will not be allowed anymore on the European market in a few years,' Laura Clays from Euroconsumers and the Belgian consumer protection group Test-Achats told Euronews Health. Beyond these potential risks, some people with sensitive skin prefer mineral sunscreens, which use ingredients like zinc oxide and titanium dioxide, because they are less likely to cause skin irritation, Clays said. However, when her group ran consumer tests, several mineral-only formulas offered weaker SPF protection than their labels claimed, meaning 'the ones that contain only mineral filters do not protect you enough,' she said. Because the sunscreen does not absorb into the skin, people should make sure they are fully covered. That could be another challenge, according to Clays' tests: people tended to reapply mineral sunscreens less often, partly because they disliked the thin layer of white residue it left on their skin. But when used correctly, both chemical and mineral sunscreens are widely considered safe and effective by dermatologists and health authorities. 'In principle, all sunscreen filters have a safety profile that has been regulatory-wise assessed and deemed safe,' Surber said. Ultimately, skin experts agree: the best sunscreen is the one you will actually use on a regular basis. 'There's really no big difference, health-wise, between the two,' Clays said.
LeMonde
5 days ago
- LeMonde
Contraceptives destroyed in silence: 'Can France accept to become the executor of a senseless policy imposed by the US?'
A stockpile of several million doses of contraceptives, valued at $9.7 million, financed by USAID and usable until 2031, is currently being incinerated in France. These products, originally intended for women in extreme poverty in countries in the Global South, are being destroyed for purely ideological reasons, at the request of the Trump administration. The service provider tasked with the incineration has not yet been identified. This human and environmental waste must be stopped immediately. Why is this happening? Because the US administration, following a blinkered ideological agenda, ordered their destruction as part of the dismantling of USAID. It even refused to transfer the stock to NGOs who were ready to transport and distribute it. This is not a public health issue or a logistical problem. It is a radical political choice. USAID's logistics program, which is usually operated by the company Chemonics, appears to be linked to this operation. However, this cannot be confirmed, since neither the name of the logistics provider nor the name of the incinerator has been made public. The stock, which was previously stored in Belgium, was transported to France in about 10 trucks at the end of July. The exact location of the incineration is deliberately undisclosed. Despite the scale of the operation, the company responsible for handling the medical waste has not been identified. We contacted four major French waste management companies to ask whether they were involved in this operation. All replied that they were not concerned. An economic and environmental absurdity As NGOs active in several African countries, we know exactly what a contraceptive shortage means: unintended pregnancies, abandoned children, unsafe abortions, and girls forced out of school at age 12. It also means women trapped in unwanted motherhood. Can France accept to become the executor of a senseless policy imposed by the US without reaction? This destruction is also an economic and environmental absurdity. It costs more ($167,000) than it would to redistribute contraceptives to countries experiencing shortages. Eliminating usable products that are urgently needed in empty health centers will also generate metric tons of CO₂. It's a total waste.
